Cancer Research

#Ariceum Therapeutics #Cancer research #Meet the Researcher #Radiopharmaceuticals

Meet the researcher: Germo Gericke, Ariceum Therapeutics

Germo Gericke, Ariceum Therapeutics, tells DDW's Megan Thomas about his work in radiopharmaceuticals for the treatment of cancer and offers valuable advice to others in this field. 1. Where do you work, and can you tell us what you’re working on at the moment? I am the Chief Medical Officer… Read More

#Cancer Research #Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Cancer research #Genetics / genomics #Oncology

Open science, genomics, and the quiet revolution in our approach to pharma

Listen to this article on the DDW Podcast: Evan Floden, CEO of Seqera Labs examines how data sharing platforms are impacting cancer and genomics research. The tide has been turning in the worlds of diagnostics and drug development. Bioinformatics and genetic sequencing are starting to be placed front and centre of… Read More

#Cancer Research #Exclusive Content

CRISPR gene editing
#Cancer research #CAR-T #CRISPR #CRISPR-Cas9 #Gene editing #Oncology

CRISPR breakthroughs: New solutions for common diseases

Listen to this article on the DDW Podcast: Rolf Turk, Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Since its discovery in 2012, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionised the biomedicine and cell and gene therapy fields,… Read More

#Cancer Research #Exclusive Content

#Artificial intelligence (AI) #Cancer research #Collaboration #Oncology #Precision medicine #The Institute of Cancer Research #Vivan Therapeutics

AI discovery collaboration targets precision cancer drugs

Researchers will combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future. Under an academic and commercial collaboration between The Institute of Cancer Research, London, the Bellvitge Biomedical Research… Read More

#Cancer Research #News

Lung cancer
#Cancer research #Immunotherapy #Lung cancer #Oncology #Roche #University College London

Immunotherapy improves lung cancer long-term survival

A global study, led by University College London (UCL) and University College London Hospitals (UCLH) and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer (NSCLC) patients, when compared to single-agent chemotherapy. For… Read More

#Cancer Research #News

Cancer immuno-oncology
#AI / data analytics / healthtech / informatics #Bispecific Antibodies #Bispecific therapeutics #Cambridge Healthtech Institute #Cancer immunotherapy #Events #Immuno-oncology #Next generation sequencing

Immuno-Oncology Summit Europe 2023: Programme highlights 

From June 20-22, 2023, Cambridge Healthtech Institute hosted the seventh annual Immuno-Oncology Summit Europe in London. DDW’s Megan Thomas shares highlights from the event programmes.   Programmes   This year’s summit was made up of conference programmes, which included: Modulating the Tumour Microenvironment; Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and… Read More

#Cancer Research #Exclusive Content #Opinion

Natural killer cells
#Cancer research #Cell therapy #EU patent #iPSC #Oncology #ONK Therapeutics

ONK secures European patent for CISH knockout in NK cells

The European Patent Office (EPO) has granted a licensed patent to ONK Therapeutics covering CISH knockout (KO) in natural killer (NK) cells, irrespective of the source of the NK cells. The patent includes human cord blood-derived, peripheral blood-derived, and NK cells derived from induced pluripotent stem… Read More

#Cancer Research #News

Cancer research lab
#Cancer research #Cancer Research UK #Clinical trial design #Oncology #Precision medicine

Cancer Research UK joins precision cancer medicine consortium

Cancer Research UK has joined the PRIME-ROSE project, a Europe-wide effort to boost patient access to precision cancer medicine (PCM). The PRIME-ROSE consortium consists of 24 partners, including nine beneficiaries and fifteen associated partners who will come together over the course of five years and work… Read More

#Cancer Research #News

T cells
#Antibodies #Cancer research #Immunotherapy #Oncology #T cell activation #Transcriptomics

Discovery could lead to more efficient cancer therapies

Scientists from Japan have identified regulator CD69, which controls the differentiation of CD8+ T cells within tumour-draining lymph nodes, thereby regulating anti-tumour immunity. Future cancer treatment based on antibodies against CD69 could enhance anti-tumour immune responses of CD8+ T cells and lead to more efficient cancer… Read More

#Cancer Research #News

#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Meet the researcher: Vito Palombella, Surface Oncology 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Vito Palombella, Chief Scientific Officer at Surface Oncology.  MT: Where do you work, and… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Don’t miss AACR 2023 on the DDW Events podcast 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, which took place in April 2023, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research, who you will hear from across three episodes of the… Read More

#Cancer Research #News #Opinion

Cancer cells
#American Society of Clinical Oncology #Breast cancer #Cancer research #HER2 #Oncology #The College of American Pathologists

Updates to HER2 testing guidelines reduces confusion 

The College of American Pathologists (CAP) and American Society of Clinical Oncology (ASCO) have reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.  The recent clinical trial for metastatic breast cancer patients (DESTINY-Breast04) found that a treatment traditionally… Read More

#Cancer Research #News #Regulatory #Trending News

#AACR 2023 #Cancer research #CAR-T #DDW Events podcast #Meet the Researcher #T cell receptor (TCR) #Triumvira Immunologics

Meet the researcher: Andreas Bader, Triumvira Immunologics

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Andreas Bader, Chief Scientific Officer at Triumvira Immunologics. MT: Where do you work, and… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR 2023 #Cancer research #DDW Events podcast #Kintara Therapeutics #Meet the Researcher #Therapeutics

Meet the researcher: Dennis Brown, Kintara Therapeutics 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Dennis Brown, Chief Scientific Officer at Kintara Therapeutics. You can also listen to these… Read More

#Cancer Research #Exclusive Content #Opinion

Audience
#ASCO #Cancer research #Immutep #Oncology #Phase II trial

Immutep reports positive final data at ASCO 2023

Immutep revealed positive final data from Part C of the TACTI-002 Phase II trial at the ASCO 2023 Annual Meeting in Chicago, US. The trial evaluated eftilagimod alpha (efti), a soluble LAG-3 protein and first-in-class MHC Class II agonist, in combination with MSD’s (Merck) anti-PD-1 therapy Keytruda… Read More

#Cancer Research #News